Frequency of Dyslipidemias in Non-Diabetic and Obese Subjects

被引:0
|
作者
Samreen, Sarah [1 ]
Saleemi, Amber [2 ]
Chachar, Aijaz Zeeshan Khan [3 ]
Raza, Mohsin [1 ]
Abid, Syed Hussain [4 ]
Iqbal, Sadia [5 ]
机构
[1] Fatima Jinnah Med Univ, Sir Ganga Ram Hosp, Lahore, Pakistan
[2] King Edward Med Univ, Mayo Hosp, Lahore, Pakistan
[3] Fatima Mem Hosp Coll Med & Dent, Lahore, Pakistan
[4] Mayo Hosp, Lahore, Pakistan
[5] Sir Ganga Ram Hosp, Lahore, Pakistan
来源
关键词
Dyslipidemia; Obesity; Total cholesterol; Triglycerides; Low density lipoprotein; POPULATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity is now considered as an emerging epidemic worldwide. It is associated with dyslipidemias and is considered independent cardiovascular risk factor in many subjects. Obesity and its metabolic consequences are worldwide epidemics. Aim: To determine frequency of dyslipidemias in non-diabetic obese subjects presenting to a tertiary care hospital in Lahore. Methods: This cross sectional study was carried out in medical inpatient and outpatient departments of Sir Ganga ram Hospital, Lahore during six months, from 12th August 2016 to 11th February 2017. Patients were interviewed for absence of diabetes mellitus, hypertension, renal, hepatic or cardiac disease, family history of dyslipidemias, smoking and drinking alcohol. Body weight in kilograms and height in centimeters was measured to calculate BMI. Results: There were 93 (46.5%) males and 107(53.5%) females. The mean BMI of patients was 36.07 +/- 3.25 kg/m(2); 79 (39.5%) patients with grade I obesity (BMI 30.0-34.9 kg/m(2)), 92 (46%) patients with grade II obesity (BMI 35.0-39.9 kg/m(2)) and 29 (14.5%) patients with grade III obesity (BMI >= 40.0 kg/m(2)). Raised total cholesterol >200mg/dl was present in 155(77.5%) patients and absent in 45(22.5%) patients. Conclusion: Prevalence of dyslipidemia was both age and body mass index dependent. Dyslipidemia showed an increasing trend with age >= 38 years. Patients with increased body mass index had increased prevalence of dyslipidemia which is an eye opener for the health policy makers to devise the strategies to delay the onset of this preventable disease.
引用
收藏
页码:717 / 721
页数:5
相关论文
共 50 条
  • [11] Risk factors for coronary heart disease in obese non-diabetic subjects
    Whitelaw, DC
    O'Kane, M
    Wales, JK
    Barth, JH
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (07) : 1042 - 1046
  • [12] OBESE NON-DIABETIC PATINETS
    STOWERS, JM
    BEWSHER, PD
    BRITISH MEDICAL JOURNAL, 1970, 1 (5692): : 366 - &
  • [13] Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients
    Paquot, N
    Scheen, AJ
    Dirlewanger, M
    Lefèbvre, PJ
    Tappy, L
    OBESITY RESEARCH, 2002, 10 (03): : 129 - 134
  • [14] GLUCOSE METABOLITES IN BLOOD AND ADIPOSE-TISSUE OF OBESE DIABETIC AND NON-DIABETIC SUBJECTS
    PAGE, MA
    GALTON, DJ
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (01): : 27 - 32
  • [15] FFA stimulate insulin secretion equally in obese diabetic and non-diabetic subjects.
    Boden, G
    Chen, XH
    DIABETES, 1997, 46 : 800 - 800
  • [16] RELATIVE UNRESPONSIVENESS OF OBESE DIABETIC COMPARED TO OBESE NON-DIABETIC SUBJECTS TO WEIGHT-REDUCING EFFECT OF FENFLURAMINE
    OTIM, MA
    EAST AFRICAN MEDICAL JOURNAL, 1977, 54 (02) : 91 - 95
  • [17] ASSOCIATIONS OF CHEMERIN LEVELS AND LIPID SUBFRACTIONS IN NON-DIABETIC OBESE AND LEAN SUBJECTS
    Seres, I.
    Lorincz, H.
    Katko, M.
    Harangi, M.
    Somodi, S.
    Gaal, K.
    Fulop, P.
    Paragh, G.
    ATHEROSCLEROSIS, 2014, 235 (02) : E220 - E220
  • [18] Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects
    Gatti, Alessandra
    Morini, Eleonora
    De Cosmo, Salvatore
    Maiani, Francesca
    Mandosi, Elisabetta
    Fallarino, Mara
    Morano, Susanna
    Trischitta, Vincenzo
    OBESITY, 2008, 16 (04) : 899 - 901
  • [19] Troglitazone inhibits PPARγ expression in mononuclear cells in obese non-diabetic subjects
    Aljada, A
    Ghanim, H
    Assian, E
    Garg, R
    Mohanty, P
    Dandona, P
    DIABETES, 2000, 49 : A105 - A105
  • [20] Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects
    M. Zhang
    L. F. Bi
    J. H. Fang
    X. L. Su
    G. L. Da
    T. Kuwamori
    S. Kagamimori
    Amino Acids, 2004, 26 : 267 - 271